FRUZAQLA caps 5 mg bte 21 pce
7680695240023
CH-69524
L01EK04
07.16.1.
Reimbursement limitations:
FRUZAQLA
FRUZAQLA est remboursé après accord sur la prise en charge des frais par l’assureur-maladie, après …
1 / 3
google
Details
- Product number
- 6952402
- CPT
- -
- Packaging group
- 21
- Unit
- Kapsel(n)
- Composition
- fruquintinibum 5 mg, maydis amylum, cellulosum microcristallinum, talcum, Kapselhülle: gelatina, E 171, E 133, E 129 0.1829 mg, Drucktinte: lacca, propylenglycolum, kalii hydroxidum, E 172 (nigrum), pro capsula.
Articles (1)
Fruzaqla 5 mg, Hartkapseln
Kapseln
21
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
5.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FNIDK |
|
(N/A)
|
- | Substance | FIMDK |
|
(N/A)
|
0.1829 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FTODK |
Reimbursement information
Public price
CHF 4130.55
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/01/2025
Authorization holder
Takeda Pharma AG
8152 Opfikon
Authorization information
- Swissmedic authorization number
- 69524
- Drug name
- Fruzaqla, Hartkapseln
- Galenic form
- KAHA
- ATC Code
- L01EK04
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 27/08/2024
- Authorization expiration date
- 26/08/2029
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- FRUZAQLA caps 5 mg bte 21 pce
- Description (DE)
- FRUZAQLA Kaps 5 mg Ds 21 Stk
- Market launch
- 27/08/2024
- Narcotic (BTM)
- No